UNITED GUARDIAN INC
UGNASDAQTrading Snapshot
- Day Range
- $6.61 β $6.91
- 52-Week Range
- $5.58 β $8.45
- Volume (shares)
- 12,466
- Avg Volume (shares)
- β
- Shares Outstanding
- 4.6M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $11M
- Last Q Revenue
- $3M
- P/E Ratio
- 12.5
- P/S Ratio
- 2.7x
- EPS (TTM)
- $0.54
- Dividend Yield
- 7.48%
- Dilution (1yr)
- +0.0%
UNITED GUARDIAN INC
UGAbout UNITED GUARDIAN INC
United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates

Contrasting GSK (NYSE:GSK) and United-Guardian (NASDAQ:UG)
GSK (NYSE: GSK - Get Free Report) and United-Guardian (NASDAQ: UG - Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividen

Upside Gold Announces September Investor Outreach Schedule
CALGARY, Alberta β TheNewswire - September 16, 2026Β β Upside Gold Corp. (βUpsideβ or the βCompanyβ) (CSE: UG) (FSE: 47I) (OTCQB: UGODF)Β is pleased to announce its September investor outreach schedule, including participa

UG Q2 Earnings Rise Y/Y on Strong Cosmetic Ingredient Sales
United-Guardian's cosmetic ingredient growth supports higher Q2 sales and earnings per share, while other income also strengthens the results.

United-Guardian Reports Second Quarter Results
HAUPPAUGE, N.Y., Aug. 07, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the second quarter and first half of 2026. Second quarter net sales increased by 10% from $2,